{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T17:06:08Z","timestamp":1787763968832,"version":"build-2784847793"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ijbiomac.2025.145733","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T12:17:30Z","timestamp":1751545050000},"page":"145733","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P1","title":["GLP1 secretagogue cinnamaldehyde upregulates GLP1\/PI3K\/AKT and Nrf2 pathways to exert neuroprotection in a rotenone induced mouse model of Parkinson's disease"],"prefix":"10.1016","volume":"320","author":[{"given":"Kirti","family":"Mathur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritu","family":"Soni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruchi","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhumika D.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jigna","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.145733_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2017.13","article-title":"Parkinson disease","volume":"3","author":"Poewe","year":"2017","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0010","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1021\/acschemneuro.2c00165","article-title":"Deciphering intertwined molecular pathways underlying metabolic syndrome leading to Parkinson\u2019s disease","volume":"13","author":"Soni","year":"2022","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0015","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4103\/apjtb.apjtb_229_24","article-title":"C-phycocyanin shows neuroprotective effect against rotenone-induced Parkinson\u2019s disease in mice","volume":"14","author":"Rathod","year":"2024","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102208","article-title":"An update on new-age potential biomarkers for Parkinson\u2019s disease","volume":"94","author":"Soni","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0025","doi-asserted-by":"crossref","DOI":"10.1021\/acsptsci.4c00586","article-title":"Hyperglycemia-driven insulin signaling defects promote Parkinson\u2019s disease-like pathology in mice","author":"Soni","year":"2024","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0030","doi-asserted-by":"crossref","first-page":"6834","DOI":"10.1007\/s12035-022-03005-z","article-title":"Chlorogenic acid: a polyphenol from coffee rendered neuroprotection against rotenone-induced Parkinson\u2019s disease by GLP-1 secretion","volume":"59","author":"Sharma","year":"2022","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0035","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1468-1331.2008.02056.x","article-title":"Non-motor symptoms in Parkinson\u2019s disease","volume":"15","author":"Poewe","year":"2008","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0040","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/WCO.0b013e3283542fc2","article-title":"Therapies in Parkinson\u2019s disease","volume":"25","author":"Jankovic","year":"2012","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2025.140789","article-title":"Unveiling the significance of synaptic proteins in parkinson\u2019s pathogenesis: a review","volume":"304","author":"Soni","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0050","article-title":"Cinnamaldehyde attenuates the expression of IBA1 and GFAP to inhibit glial cell activation and inflammation in the MPTP-induced acute Parkinson\u2019s disease model","volume":"2024","author":"Jiao","year":"2024","journal-title":"Parkinsons Dis"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0055","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19020551","article-title":"The neuroprotective effects of cinnamic aldehyde in an MPTP mouse model of parkinson\u2019s disease","volume":"19","author":"Bae","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0060","doi-asserted-by":"crossref","DOI":"10.3390\/ani11082262","article-title":"Cinnamaldehyde induces release of cholecystokinin and glucagon-like peptide 1 by interacting with transient receptor potential ankyrin 1 in a porcine ex-vivo intestinal segment model","volume":"11","author":"Van Liefferinge","year":"2021","journal-title":"Animals"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijgfs.2023.100858","article-title":"Cinnamon: the historic spice, medicinal uses, and flavour chemistry","volume":"35","author":"Spence","year":"2024","journal-title":"Int J Gastron Food Sci"},{"issue":"37","key":"10.1016\/j.ijbiomac.2025.145733_bb0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5530\/phrev.20252106","article-title":"Natural bioactives targeting the GLP-1 pathway: A promising approach for diabetes management","volume":"19","author":"Kolhe","year":"2025","journal-title":"Pharmacogn. Rev."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0075","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3233\/JPD-171192","article-title":"Is exenatide a treatment for Parkinson\u2019s disease?","volume":"7","author":"Athauda","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0080","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s11481-014-9552-2","article-title":"Cinnamon treatment upregulates neuroprotective proteins Parkin and DJ-1 and protects dopaminergic neurons in a mouse model of Parkinson\u2019s disease","volume":"9","author":"Khasnavis","year":"2014","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0085","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.4c00729","article-title":"Dual GLP-1 and GIP agonist tirzepatide exerted neuroprotective action in a Parkinson\u2019s disease rat model","author":"Delvadia","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0090","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1039\/C4FO00680A","article-title":"Anti-inflammatory activity of cinnamon (C. zeylanicum and C. cassia) extracts \u2013 identification of E-cinnamaldehyde and o-methoxy cinnamaldehyde as the most potent bioactive compounds","volume":"6","author":"Gunawardena","year":"2015","journal-title":"Food Funct."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0095","doi-asserted-by":"crossref","first-page":"73","DOI":"10.14715\/cmb\/2017.63.6.15","article-title":"Pharmacological activities of cinnamaldehyde and eugenol: antioxidant, cytotoxic and anti-leishmanial studies","volume":"63","author":"Sharma","year":"2017","journal-title":"Cell. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0100","doi-asserted-by":"crossref","first-page":"5164","DOI":"10.1021\/jf200579h","article-title":"Cinnamaldehyde enhances Nrf2 nuclear translocation to upregulate phase II detoxifying enzyme expression in HepG2 cells","volume":"59","author":"Huang","year":"2011","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0105","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41374-018-0025-8","article-title":"Cinnamaldehyde accelerates wound healing by promoting angiogenesis via up-regulation of PI3K and MAPK signaling pathways","volume":"98","author":"Yuan","year":"2018","journal-title":"Lab. Investig."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0110","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.3892\/or.2015.4493","article-title":"Cinnamaldehyde affects the biological behavior of human colorectal cancer cells and induces apoptosis via inhibition of the PI3K\/Akt signaling pathway","volume":"35","author":"Li","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0115","series-title":"Ann N Y Acad Sci","first-page":"61","article-title":"The Nrf2-ARE pathway: an indicator and modulator of oxidative stress in neurodegeneration","author":"Johnson","year":"2008"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0120","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1111\/jnc.13087","article-title":"Neuroprotective effects of vildagliptin in rat rotenone Parkinson\u2019s disease model: role of RAGE-NF\u03baB and Nrf2-antioxidant signaling pathways","volume":"133","author":"Abdelsalam","year":"2015","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0125","doi-asserted-by":"crossref","first-page":"5525","DOI":"10.1523\/JNEUROSCI.4777-09.2010","article-title":"Decaffeinated coffee and nicotine-free tobacco provide neuroprotection in Drosophila models of Parkinson\u2019s disease through an NRF2-dependent mechanism","volume":"30","author":"Trinh","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0130","article-title":"GSK-3 in neurodegenerative diseases","volume":"2011","author":"Lei","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2023.115496","article-title":"GSK-3\u03b2: an exuberating neuroinflammatory mediator in Parkinson\u2019s disease","volume":"210","author":"Samim Khan","year":"2023","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0140","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1242\/jcs.138057","article-title":"GSK-3 -at the crossroads of cell death and survival","volume":"127","author":"Maurer","year":"2014","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0145","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep38553","article-title":"GSK-3\u03b2 controls NF-kappaB activity via IKK\u03b3\/NEMO","volume":"6","author":"Medunjanin","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0150","series-title":"GSK-3\u03b2 Inhibitors Can Rescue Neurons Through the Prosurvival (Autophagy) Mechanism in Parkinson\u2019s Disease","author":"Joshi","year":"2022"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.136045","article-title":"Nurr1 downregulation is caused by CREB inactivation in a Parkinson\u2019s disease mouse model","volume":"759","author":"Xu","year":"2021","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0160","article-title":"Open Babel: an open chemical toolbox","volume":"3","author":"O\u2019Boyle","year":"2011","journal-title":"J Cheminform"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0165","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.1021\/acs.jcim.1c00203","article-title":"AutoDock Vina 1.2.0: new docking methods, expanded force field, and Python bindings","volume":"61","author":"Eberhardt","year":"2021","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0170","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0175","series-title":"4th International Conference on Computational Physics (PC 92)","article-title":"Gromacs-a parallel computer for molecular-dynamics simulations","author":"Bekker","year":"1993"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0180","doi-asserted-by":"crossref","first-page":"6665","DOI":"10.1073\/pnas.0408037102","article-title":"Potential energy functions for atomic-level simulations of water and organic and biomolecular systems","volume":"102","author":"Jorgensen","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0185","doi-asserted-by":"crossref","first-page":"3864","DOI":"10.1021\/acs.jpcb.7b00272","article-title":"1.14*CM1A-LBCC: localized bond-charge corrected CM1A charges for condensed-phase simulations","volume":"121","author":"Dodda","year":"2017","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0190","doi-asserted-by":"crossref","first-page":"W331","DOI":"10.1093\/nar\/gkx312","article-title":"LigParGen web server: an automatic OPLS-AA parameter generator for organic ligands","volume":"45","author":"Dodda","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0195","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1111\/bph.13270","article-title":"Cinnamaldehyde inhibits inflammation and brain damage in a mouse model of permanent cerebral ischaemia","volume":"172","author":"Zhao","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0200","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0254-6272(13)60053-9","article-title":"Antihyperglycemic and antihyperlipidemic action of cinnamalde-hyde in C57blks\/j Db\/db mice","volume":"32","author":"Li","year":"2012","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0205","author":"Mehraein"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0210","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.thromres.2006.03.001","article-title":"Cinnamaldehyde reduction of platelet aggregation and thrombosis in rodents","volume":"119","author":"Huang","year":"2007","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e33860","article-title":"AutoDock and molecular dynamics-based therapeutic potential prediction of flavonoids for primary Sj\u00f6gren\u2019s syndrome","volume":"10","author":"Mao","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0220","first-page":"1","article-title":"The regulatory network of gastric cancer pathogenesis and its potential therapeutic active ingredients of traditional Chinese medicine based on bioinformatics, molecular docking, and molecular dynamics simulation","volume":"2022","author":"Yang","year":"2022","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0225","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000039569","article-title":"Network pharmacology integrated with molecular docking and molecular dynamics simulations to explore the mechanism of Tongxie Yaofang in the treatment of ulcerative colitis","volume":"103","author":"Tang","year":"2024","journal-title":"Medicine"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0230","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1172\/JCI46045","article-title":"PKC\u03b4 regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans","volume":"121","author":"Bezy","year":"2011","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0235","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.973058","article-title":"The role of protein kinase C in diabetic microvascular complications","volume":"13","author":"Pan","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0240","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1161\/CIRCRESAHA.110.217117","article-title":"Activation of protein kinase C isoforms and its impact on diabetic complications","volume":"106","author":"Geraldes","year":"2010","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0245","article-title":"The active components of Erzhi wan and their anti-Alzheimer\u2019s disease mechanisms determined by an integrative approach of network pharmacology, bioinformatics, molecular docking, and molecular dynamics simulation","volume":"10","author":"Yu","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0250","doi-asserted-by":"crossref","DOI":"10.1021\/acschemneuro.5c00112","article-title":"Upregulation of the PI3K\/AKT and Nrf2 pathways by the DPP-4 inhibitor sitagliptin renders neuroprotection in chemically induced Parkinson\u2019s disease mouse models","author":"Soni","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22720","article-title":"Neuroprotective potential of cinnamon and its metabolites in Parkinson\u2019s disease: mechanistic insights, limitations, and novel therapeutic opportunities","volume":"35","author":"Angelopoulou","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0260","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.neuropharm.2017.09.023","article-title":"Protective effects of the GLP-1 mimetic exendin-4 in Parkinson\u2019s disease","volume":"136","author":"Athauda","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0265","article-title":"Recent advances in understanding GLP-1R (glucagon-like peptide-1 receptor) function","volume":"41","author":"Savage","year":"2013","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0270","first-page":"2294","article-title":"Distribution of GLP-1 binding sites in the rat brain: evidence that exendin-4 is a ligand of brain GLP-1 binding sites","volume":"7","author":"Gdke","year":"1995"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0275","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1152\/physrev.00013.2014","article-title":"Physiology of proglucagon peptides: role ofglucagon and GLP-1 in health and disease","volume":"95","author":"Sandoval","year":"2015","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0280","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.ejphar.2013.06.015","article-title":"Treatment with exendin-4 improves the antidiabetic efficacy and reverses hepatic steatosis in glucokinase activator treated db\/db mice","volume":"714","author":"Dhanesha","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0285","series-title":"Improvement of Levodopa-induced Dyskinesia by Propranolol in Parkinson\u2019s Disease","author":"Carpentier","year":"1996"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0290","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.140532","article-title":"Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist","volume":"5","author":"Willard","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0295","first-page":"197","article-title":"GLP-1 secretagogues potential of medicinal plants in management of diabetes","volume":"4","author":"Singh","year":"2015","journal-title":"Journal of Pharmacognosy and Phytochemistry"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0300","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.biochi.2020.01.004","article-title":"Naturally occurring cinnamic acid derivatives prevent amyloid transformation of alpha-synuclein","volume":"170","author":"Medvedeva","year":"2020","journal-title":"Biochimie"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0305","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1289\/ehp.1002839","article-title":"Rotenone, paraquat, and Parkinson\u2019s disease","volume":"119","author":"Tanner","year":"2011","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0310","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s11064-017-2176-1","article-title":"Hydroxysafflor yellow a improves motor dysfunction in the rotenone-induced mice model of Parkinson\u2019s disease","volume":"42","author":"Wang","year":"2017","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0315","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/15548627.2017.1390636","article-title":"Piperlongumine restores the balance of autophagy and apoptosis by increasing BCL2 phosphorylation in rotenone-induced Parkinson disease models","volume":"14","author":"Liu","year":"2018","journal-title":"Autophagy"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0320","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s12640-021-00436-9","article-title":"Intranasal exposure to low-dose rotenone induced alpha-synuclein accumulation and Parkinson\u2019s like symptoms without loss of dopaminergic neurons","volume":"40","author":"Sharma","year":"2022","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0325","article-title":"Progression of Parkinson's disease pathology is reproduced by intragastric administration of rotenone in mice","volume":"5","author":"Pan-montojo","year":"2010"},{"key":"10.1016\/j.ijbiomac.2025.145733_bb0330","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuro.2014.12.002","article-title":"An update on the rotenone models of Parkinson\u2019s disease: their ability to reproduce the features of clinical disease and model gene-environment interactions","volume":"46","author":"Johnson","year":"2015","journal-title":"Neurotoxicology"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025062889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813025062889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,27]],"date-time":"2025-12-27T09:24:14Z","timestamp":1766827454000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813025062889"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":66,"alternative-id":["S0141813025062889"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145733","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP1 secretagogue cinnamaldehyde upregulates GLP1\/PI3K\/AKT and Nrf2 pathways to exert neuroprotection in a rotenone induced mouse model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.145733","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"145733"}}